Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Ascertaining Diagnosis Classification With Elicited Speech

NCT05601063 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.

NCT NCT05601063
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05601063 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Ascertaining Diagnosis Classification With Elicited Speech
Lead sponsor
Northwell Health
Phase
Observational
Overall status
Completed
Start date
October 1, 2020
Completion date
September 1, 2022
Enrollment
255 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

anxiety disorders, attention deficit hyperactivity disorder, bipolar and related disorders, depressive disorder, personality disorders, schizophrenia spectrum and other psychotic disorders